Tnf Pharmaceuticals, Stock Analysis
TNFA Stock | 1.36 0.11 7.48% |
TNF Pharmaceuticals, is overvalued with Real Value of 1.17 and Hype Value of 1.34. The main objective of TNF Pharmaceuticals, stock analysis is to determine its intrinsic value, which is an estimate of what TNF Pharmaceuticals, is worth, separate from its market price. There are two main types of TNF Pharmaceuticals,'s stock analysis: fundamental analysis and technical analysis.
The TNF Pharmaceuticals, stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and TNF Pharmaceuticals,'s ongoing operational relationships across important fundamental and technical indicators.
TNF |
TNF Stock Analysis Notes
About 40.0% of the company shares are owned by institutional investors. The company has price-to-book ratio of 0.44. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. TNF Pharmaceuticals, recorded a loss per share of 10.48. The entity last dividend was issued on the 25th of November 2019. The firm had 1:30 split on the 15th of February 2024. To find out more about TNF Pharmaceuticals, contact the company at 856 848 8698 or learn more at https://tnfpharma.com.TNF Pharmaceuticals, Investment Alerts
Many investors view ongoing market volatility as an opportunity to purchase more stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. TNF Pharmaceuticals,'s investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding TNF Pharmaceuticals, or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
TNF Pharmaceuticals, had very high historical volatility over the last 90 days | |
TNF Pharmaceuticals, may become a speculative penny stock | |
TNF Pharmaceuticals, was previously known as MyMD Pharmaceuticals and was traded on NASDAQ Exchange under the symbol MYMD. | |
Net Loss for the year was (4 M) with profit before overhead, payroll, taxes, and interest of 0. | |
TNF Pharmaceuticals, generates negative cash flow from operations | |
TNF Pharmaceuticals, has a poor financial position based on the latest SEC disclosures | |
Latest headline from businesswire.com: TNF Pharmaceuticals Announces Trial to Explore Effects of Lead Candidate in SarcopeniaFrailty Induced by GLP-1 Weight Loss Drugs |
TNF Largest EPS Surprises
Earnings surprises can significantly impact TNF Pharmaceuticals,'s stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
---|---|---|---|---|---|---|---|
2017-08-15 | 2017-06-30 | -460.8 | -921.6 | -460.8 | 100 | ||
2017-12-31 | 2017-12-31 | 691.2 | -2304.0 | -2995.2 | 433 |
TNF Market Capitalization
The company currently falls under 'Nano-Cap' category with a current market capitalization of 3.13 M.TNF Profitablity
Last Reported | Projected for Next Year | ||
Return On Tangible Assets | (0.54) | (0.57) | |
Return On Capital Employed | (1.33) | (1.26) | |
Return On Assets | (0.22) | (0.24) | |
Return On Equity | (0.31) | (0.33) |
Management Efficiency
TNF Pharmaceuticals, has return on total asset (ROA) of (0.3243) % which means that it has lost $0.3243 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (2.9763) %, meaning that it created substantial loss on money invested by shareholders. TNF Pharmaceuticals,'s management efficiency ratios could be used to measure how well TNF Pharmaceuticals, manages its routine affairs as well as how well it operates its assets and liabilities. As of December 23, 2024, Return On Tangible Assets is expected to decline to -0.57. The current year's Return On Capital Employed is expected to grow to -1.26. At present, TNF Pharmaceuticals,'s Total Assets are projected to decrease significantly based on the last few years of reporting. The current year's Other Assets is expected to grow to 1.21, whereas Non Current Assets Total are forecasted to decline to about 10.1 M.Last Reported | Projected for Next Year | ||
Book Value Per Share | 8.28 | 7.87 | |
Tangible Book Value Per Share | 1.47 | 1.40 | |
Enterprise Value Over EBITDA | (0.07) | (0.07) | |
Price Book Value Ratio | 0.23 | 0.24 | |
Enterprise Value Multiple | (0.07) | (0.07) | |
Price Fair Value | 0.23 | 0.24 | |
Enterprise Value | 313.9 K | 329.6 K |
The strategic decisions made by TNF Pharmaceuticals, management significantly impact its financial stability and market performance. Evaluating these factors helps determine whether the stock is a worthwhile investment.
Beta 2.673 | Return On Assets (0.32) | Return On Equity (2.98) |
Technical Drivers
As of the 23rd of December, TNF Pharmaceuticals, has the coefficient of variation of 1910.81, and Risk Adjusted Performance of 0.0505. In connection with fundamental indicators, the technical analysis model makes it possible for you to check practical technical drivers of TNF Pharmaceuticals,, as well as the relationship between them.TNF Pharmaceuticals, Price Movement Analysis
Incorrect Input. Please change your parameters or increase the time horizon required for running this function. The output start index for this execution was zero with a total number of output elements of zero. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. TNF Pharmaceuticals, middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for TNF Pharmaceuticals,. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
TNF Pharmaceuticals, Predictive Daily Indicators
TNF Pharmaceuticals, intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of TNF Pharmaceuticals, stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
TNF Pharmaceuticals, Forecast Models
TNF Pharmaceuticals,'s time-series forecasting models are one of many TNF Pharmaceuticals,'s stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary TNF Pharmaceuticals,'s historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.About TNF Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how TNF Pharmaceuticals, prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling TNF shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as TNF Pharmaceuticals,. By using and applying TNF Stock analysis, traders can create a robust methodology for identifying TNF entry and exit points for their positions.
Last Reported | Projected for Next Year | ||
Pretax Profit Margin | (7.49) | (7.12) | |
Operating Profit Margin | (4.62) | (4.39) | |
Net Loss | (7.49) | (7.12) | |
Gross Profit Margin | (0.02) | (0.02) |
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding TNF Pharmaceuticals, to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Piotroski F Score Now
Piotroski F ScoreGet Piotroski F Score based on the binary analysis strategy of nine different fundamentals |
All Next | Launch Module |
Complementary Tools for TNF Stock analysis
When running TNF Pharmaceuticals,'s price analysis, check to measure TNF Pharmaceuticals,'s market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy TNF Pharmaceuticals, is operating at the current time. Most of TNF Pharmaceuticals,'s value examination focuses on studying past and present price action to predict the probability of TNF Pharmaceuticals,'s future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move TNF Pharmaceuticals,'s price. Additionally, you may evaluate how the addition of TNF Pharmaceuticals, to your portfolios can decrease your overall portfolio volatility.
Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments |